Gürsoy, A.Atasayan, K.Doğan, Tekbaş E.İlter, E.2024-07-122024-07-1220211309-448310.52142/OMUJECM.38.4.22-s2.0-85122140409https://doi.org/10.52142/OMUJECM.38.4.2https://hdl.handle.net/20.500.12415/7128To evaluate the safety and effectiveness of myomectomy during cesarean section. The data of fifty-four pregnant who underwent cesarean myomectomy and twenty-six pregnant with uterine leiomyoma who had cesarean section without myomectomy between the years of 2017 and 2020 in our tertiary clinic were examined retrospectively. There was no significant difference in terms of maternal age, weeks of gestation, gravida, parity, use of additional uterotonics, type of leiomyoma, size of leiomyoma, cesarean indications, blood transfusion requirement, postoperative fever, preoperative hemoglobin (g/dl), change in hemoglobin (g/dl), preoperative hematocrit (%), change in hematocrit (%), length of hospital stay between the two groups (p>0.05). While no significant difference was observed according to the location of the leiomyomas between the anterior, fundal and posterior location between the two groups, cervical leiomyomas were significantly higher in the CS group (p<0.05). This study shows that cesarean myomectomy is a safe procedure in selected cases. It also offers the advantage of avoiding a second operation in patients. © 2021 Ondokuz Mayis Universitesi. All rights reserved.eninfo:eu-repo/semantics/openAccessCesareanLeiomyomaPregnancyUterine MyomectomyArticle4154Q441038